カテゴリー： Market Monitor Global, 世界, 医療/バイオ

足菌腫治療薬の世界市場見通し2023年-2029年

◆英語タイトル：Fungal Foot Drugs Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5573）◆商品コード：MMG23JU5573
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月（※2025年版があります。お問い合わせください。）
◆ページ数：75
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥468,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥608,400見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥702,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Fungal Foot Drugs Market 調査レポートは次の情報を含め、グローバルにおけるの足菌腫治療薬市場規模と予測を収録しています。・世界の足菌腫治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の足菌腫治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の足菌腫治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「クリーム」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

足菌腫治療薬のグローバル主要企業は、Bayer、 GSK、 Johnson & Johnson、 Novartis、 Bausch Health、 TEVA、 Taro Pharmaceutical、 WellSpring Pharma、 Crown Laboratories、 Medimetriks Pharmaceuticalsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、足菌腫治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の足菌腫治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の足菌腫治療薬市場：タイプ別市場シェア、2022年
・クリーム、スプレー、その他

世界の足菌腫治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の足菌腫治療薬市場：用途別市場シェア、2022年
・オフラインストア、オンラインストア

世界の足菌腫治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の足菌腫治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における足菌腫治療薬のグローバル売上、2018年-2023年
・主要企業における足菌腫治療薬のグローバル売上シェア、2022年
・主要企業における足菌腫治療薬のグローバル販売量、2018年-2023年
・主要企業における足菌腫治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Bayer、 GSK、 Johnson & Johnson、 Novartis、 Bausch Health、 TEVA、 Taro Pharmaceutical、 WellSpring Pharma、 Crown Laboratories、 Medimetriks Pharmaceuticals

*************************************************************

・調査・分析レポートの概要
足菌腫治療薬市場の定義
市場セグメント
世界の足菌腫治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の足菌腫治療薬市場規模
世界の足菌腫治療薬市場規模：2022年 VS 2029年
世界の足菌腫治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの足菌腫治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の足菌腫治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：クリーム、スプレー、その他
足菌腫治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：オフラインストア、オンラインストア
足菌腫治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別足菌腫治療薬市場規模 2022年と2029年
地域別足菌腫治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Bayer、 GSK、 Johnson & Johnson、 Novartis、 Bausch Health、 TEVA、 Taro Pharmaceutical、 WellSpring Pharma、 Crown Laboratories、 Medimetriks Pharmaceuticals
...

Fungal foot-animal, known medically as tinea pedis, is a common skin infection of the feet caused by fungus. Signs and symptoms often include itching, scaling, cracking and redness. In rare cases the skin may blister. Athlete’s foot fungus may infect any part of the foot, but most often grows between the toes.
In this report, we study the drugs for Fungal foot-animal.
This report aims to provide a comprehensive presentation of the global market for Fungal Foot Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fungal Foot Drugs. This report contains market size and forecasts of Fungal Foot Drugs in global, including the following market information:
Global Fungal Foot Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Fungal Foot Drugs Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Fungal Foot Drugs companies in 2022 (%)
The global Fungal Foot Drugs market was valued at US$ 1215.3 million in 2022 and is projected to reach US$ 1540.5 million by 2029, at a CAGR of 3.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The classification of Fungal Foot-Animal includes Cream, Spray and others
The Fungal Foot-Animal are application in Offline Store and Online Store. The most of application for Fungal Foot-Animal is used for Offline Store, and the market share of that is about 72% in 2019.
Asia Pacific is the largest consumption place, with a consumption market share nearly 42% in 2019. Following Asia Pacific, Europe and North America are the second largest consumption places with the similar consumption market share of 21% and 20% in 2019, respectively.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Fungal Foot Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fungal Foot Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Fungal Foot Drugs Market Segment Percentages, by Type, 2022 (%)
Cream
Spray
Others
Global Fungal Foot Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Fungal Foot Drugs Market Segment Percentages, by Application, 2022 (%)
Offline Store
Online Store
Global Fungal Foot Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Fungal Foot Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Fungal Foot Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Fungal Foot Drugs revenues share in global market, 2022 (%)
Key companies Fungal Foot Drugs sales in global market, 2018-2023 (Estimated), (Units)
Key companies Fungal Foot Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
GSK
Johnson & Johnson
Novartis
Bausch Health
TEVA
Taro Pharmaceutical
WellSpring Pharma
Crown Laboratories
Medimetriks Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Fungal Foot Drugs, market overview.
Chapter 2: Global Fungal Foot Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Fungal Foot Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Fungal Foot Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Fungal Foot Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Fungal Foot Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Fungal Foot Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Fungal Foot Drugs Overall Market Size
2.1 Global Fungal Foot Drugs Market Size: 2022 VS 2029
2.2 Global Fungal Foot Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Fungal Foot Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Fungal Foot Drugs Players in Global Market
3.2 Top Global Fungal Foot Drugs Companies Ranked by Revenue
3.3 Global Fungal Foot Drugs Revenue by Companies
3.4 Global Fungal Foot Drugs Sales by Companies
3.5 Global Fungal Foot Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Fungal Foot Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Fungal Foot Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Fungal Foot Drugs Players in Global Market
3.8.1 List of Global Tier 1 Fungal Foot Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Fungal Foot Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Fungal Foot Drugs Market Size Markets, 2022 & 2029
4.1.2 Cream
4.1.3 Spray
4.1.4 Others
4.2 By Type – Global Fungal Foot Drugs Revenue & Forecasts
4.2.1 By Type – Global Fungal Foot Drugs Revenue, 2018-2023
4.2.2 By Type – Global Fungal Foot Drugs Revenue, 2024-2029
4.2.3 By Type – Global Fungal Foot Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Fungal Foot Drugs Sales & Forecasts
4.3.1 By Type – Global Fungal Foot Drugs Sales, 2018-2023
4.3.2 By Type – Global Fungal Foot Drugs Sales, 2024-2029
4.3.3 By Type – Global Fungal Foot Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Fungal Foot Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Fungal Foot Drugs Market Size, 2022 & 2029
5.1.2 Offline Store
5.1.3 Online Store
5.2 By Application – Global Fungal Foot Drugs Revenue & Forecasts
5.2.1 By Application – Global Fungal Foot Drugs Revenue, 2018-2023
5.2.2 By Application – Global Fungal Foot Drugs Revenue, 2024-2029
5.2.3 By Application – Global Fungal Foot Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Fungal Foot Drugs Sales & Forecasts
5.3.1 By Application – Global Fungal Foot Drugs Sales, 2018-2023
5.3.2 By Application – Global Fungal Foot Drugs Sales, 2024-2029
5.3.3 By Application – Global Fungal Foot Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Fungal Foot Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Fungal Foot Drugs Market Size, 2022 & 2029
6.2 By Region – Global Fungal Foot Drugs Revenue & Forecasts
6.2.1 By Region – Global Fungal Foot Drugs Revenue, 2018-2023
6.2.2 By Region – Global Fungal Foot Drugs Revenue, 2024-2029
6.2.3 By Region – Global Fungal Foot Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Fungal Foot Drugs Sales & Forecasts
6.3.1 By Region – Global Fungal Foot Drugs Sales, 2018-2023
6.3.2 By Region – Global Fungal Foot Drugs Sales, 2024-2029
6.3.3 By Region – Global Fungal Foot Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Fungal Foot Drugs Revenue, 2018-2029
6.4.2 By Country – North America Fungal Foot Drugs Sales, 2018-2029
6.4.3 US Fungal Foot Drugs Market Size, 2018-2029
6.4.4 Canada Fungal Foot Drugs Market Size, 2018-2029
6.4.5 Mexico Fungal Foot Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Fungal Foot Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Fungal Foot Drugs Sales, 2018-2029
6.5.3 Germany Fungal Foot Drugs Market Size, 2018-2029
6.5.4 France Fungal Foot Drugs Market Size, 2018-2029
6.5.5 U.K. Fungal Foot Drugs Market Size, 2018-2029
6.5.6 Italy Fungal Foot Drugs Market Size, 2018-2029
6.5.7 Russia Fungal Foot Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Fungal Foot Drugs Market Size, 2018-2029
6.5.9 Benelux Fungal Foot Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Fungal Foot Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Fungal Foot Drugs Sales, 2018-2029
6.6.3 China Fungal Foot Drugs Market Size, 2018-2029
6.6.4 Japan Fungal Foot Drugs Market Size, 2018-2029
6.6.5 South Korea Fungal Foot Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Fungal Foot Drugs Market Size, 2018-2029
6.6.7 India Fungal Foot Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Fungal Foot Drugs Revenue, 2018-2029
6.7.2 By Country – South America Fungal Foot Drugs Sales, 2018-2029
6.7.3 Brazil Fungal Foot Drugs Market Size, 2018-2029
6.7.4 Argentina Fungal Foot Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Fungal Foot Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Fungal Foot Drugs Sales, 2018-2029
6.8.3 Turkey Fungal Foot Drugs Market Size, 2018-2029
6.8.4 Israel Fungal Foot Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Fungal Foot Drugs Market Size, 2018-2029
6.8.6 UAE Fungal Foot Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Bayer
7.1.1 Bayer Company Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Fungal Foot Drugs Major Product Offerings
7.1.4 Bayer Fungal Foot Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Bayer Key News & Latest Developments
7.2 GSK
7.2.1 GSK Company Summary
7.2.2 GSK Business Overview
7.2.3 GSK Fungal Foot Drugs Major Product Offerings
7.2.4 GSK Fungal Foot Drugs Sales and Revenue in Global (2018-2023)
7.2.5 GSK Key News & Latest Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Fungal Foot Drugs Major Product Offerings
7.3.4 Johnson & Johnson Fungal Foot Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Johnson & Johnson Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Fungal Foot Drugs Major Product Offerings
7.4.4 Novartis Fungal Foot Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Novartis Key News & Latest Developments
7.5 Bausch Health
7.5.1 Bausch Health Company Summary
7.5.2 Bausch Health Business Overview
7.5.3 Bausch Health Fungal Foot Drugs Major Product Offerings
7.5.4 Bausch Health Fungal Foot Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Bausch Health Key News & Latest Developments
7.6 TEVA
7.6.1 TEVA Company Summary
7.6.2 TEVA Business Overview
7.6.3 TEVA Fungal Foot Drugs Major Product Offerings
7.6.4 TEVA Fungal Foot Drugs Sales and Revenue in Global (2018-2023)
7.6.5 TEVA Key News & Latest Developments
7.7 Taro Pharmaceutical
7.7.1 Taro Pharmaceutical Company Summary
7.7.2 Taro Pharmaceutical Business Overview
7.7.3 Taro Pharmaceutical Fungal Foot Drugs Major Product Offerings
7.7.4 Taro Pharmaceutical Fungal Foot Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Taro Pharmaceutical Key News & Latest Developments
7.8 WellSpring Pharma
7.8.1 WellSpring Pharma Company Summary
7.8.2 WellSpring Pharma Business Overview
7.8.3 WellSpring Pharma Fungal Foot Drugs Major Product Offerings
7.8.4 WellSpring Pharma Fungal Foot Drugs Sales and Revenue in Global (2018-2023)
7.8.5 WellSpring Pharma Key News & Latest Developments
7.9 Crown Laboratories
7.9.1 Crown Laboratories Company Summary
7.9.2 Crown Laboratories Business Overview
7.9.3 Crown Laboratories Fungal Foot Drugs Major Product Offerings
7.9.4 Crown Laboratories Fungal Foot Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Crown Laboratories Key News & Latest Developments
7.10 Medimetriks Pharmaceuticals
7.10.1 Medimetriks Pharmaceuticals Company Summary
7.10.2 Medimetriks Pharmaceuticals Business Overview
7.10.3 Medimetriks Pharmaceuticals Fungal Foot Drugs Major Product Offerings
7.10.4 Medimetriks Pharmaceuticals Fungal Foot Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Medimetriks Pharmaceuticals Key News & Latest Developments
8 Global Fungal Foot Drugs Production Capacity, Analysis
8.1 Global Fungal Foot Drugs Production Capacity, 2018-2029
8.2 Fungal Foot Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Fungal Foot Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Fungal Foot Drugs Supply Chain Analysis
10.1 Fungal Foot Drugs Industry Value Chain
10.2 Fungal Foot Drugs Upstream Market
10.3 Fungal Foot Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Fungal Foot Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Fungal Foot Drugs in Global Market
Table 2. Top Fungal Foot Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Fungal Foot Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Fungal Foot Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Fungal Foot Drugs Sales by Companies, (Units), 2018-2023
Table 6. Global Fungal Foot Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Fungal Foot Drugs Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Fungal Foot Drugs Product Type
Table 9. List of Global Tier 1 Fungal Foot Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Fungal Foot Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Fungal Foot Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Fungal Foot Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Fungal Foot Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Fungal Foot Drugs Sales (Units), 2018-2023
Table 15. By Type - Global Fungal Foot Drugs Sales (Units), 2024-2029
Table 16. By Application – Global Fungal Foot Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Fungal Foot Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Fungal Foot Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Fungal Foot Drugs Sales (Units), 2018-2023
Table 20. By Application - Global Fungal Foot Drugs Sales (Units), 2024-2029
Table 21. By Region – Global Fungal Foot Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Fungal Foot Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Fungal Foot Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Fungal Foot Drugs Sales (Units), 2018-2023
Table 25. By Region - Global Fungal Foot Drugs Sales (Units), 2024-2029
Table 26. By Country - North America Fungal Foot Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Fungal Foot Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Fungal Foot Drugs Sales, (Units), 2018-2023
Table 29. By Country - North America Fungal Foot Drugs Sales, (Units), 2024-2029
Table 30. By Country - Europe Fungal Foot Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Fungal Foot Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Fungal Foot Drugs Sales, (Units), 2018-2023
Table 33. By Country - Europe Fungal Foot Drugs Sales, (Units), 2024-2029
Table 34. By Region - Asia Fungal Foot Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Fungal Foot Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Fungal Foot Drugs Sales, (Units), 2018-2023
Table 37. By Region - Asia Fungal Foot Drugs Sales, (Units), 2024-2029
Table 38. By Country - South America Fungal Foot Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Fungal Foot Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Fungal Foot Drugs Sales, (Units), 2018-2023
Table 41. By Country - South America Fungal Foot Drugs Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa Fungal Foot Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Fungal Foot Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Fungal Foot Drugs Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Fungal Foot Drugs Sales, (Units), 2024-2029
Table 46. Bayer Company Summary
Table 47. Bayer Fungal Foot Drugs Product Offerings
Table 48. Bayer Fungal Foot Drugs Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Bayer Key News & Latest Developments
Table 50. GSK Company Summary
Table 51. GSK Fungal Foot Drugs Product Offerings
Table 52. GSK Fungal Foot Drugs Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. GSK Key News & Latest Developments
Table 54. Johnson & Johnson Company Summary
Table 55. Johnson & Johnson Fungal Foot Drugs Product Offerings
Table 56. Johnson & Johnson Fungal Foot Drugs Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Johnson & Johnson Key News & Latest Developments
Table 58. Novartis Company Summary
Table 59. Novartis Fungal Foot Drugs Product Offerings
Table 60. Novartis Fungal Foot Drugs Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Novartis Key News & Latest Developments
Table 62. Bausch Health Company Summary
Table 63. Bausch Health Fungal Foot Drugs Product Offerings
Table 64. Bausch Health Fungal Foot Drugs Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Bausch Health Key News & Latest Developments
Table 66. TEVA Company Summary
Table 67. TEVA Fungal Foot Drugs Product Offerings
Table 68. TEVA Fungal Foot Drugs Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. TEVA Key News & Latest Developments
Table 70. Taro Pharmaceutical Company Summary
Table 71. Taro Pharmaceutical Fungal Foot Drugs Product Offerings
Table 72. Taro Pharmaceutical Fungal Foot Drugs Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Taro Pharmaceutical Key News & Latest Developments
Table 74. WellSpring Pharma Company Summary
Table 75. WellSpring Pharma Fungal Foot Drugs Product Offerings
Table 76. WellSpring Pharma Fungal Foot Drugs Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. WellSpring Pharma Key News & Latest Developments
Table 78. Crown Laboratories Company Summary
Table 79. Crown Laboratories Fungal Foot Drugs Product Offerings
Table 80. Crown Laboratories Fungal Foot Drugs Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Crown Laboratories Key News & Latest Developments
Table 82. Medimetriks Pharmaceuticals Company Summary
Table 83. Medimetriks Pharmaceuticals Fungal Foot Drugs Product Offerings
Table 84. Medimetriks Pharmaceuticals Fungal Foot Drugs Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Medimetriks Pharmaceuticals Key News & Latest Developments
Table 86. Fungal Foot Drugs Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 87. Global Fungal Foot Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Fungal Foot Drugs Production by Region, 2018-2023 (Units)
Table 89. Global Fungal Foot Drugs Production by Region, 2024-2029 (Units)
Table 90. Fungal Foot Drugs Market Opportunities & Trends in Global Market
Table 91. Fungal Foot Drugs Market Drivers in Global Market
Table 92. Fungal Foot Drugs Market Restraints in Global Market
Table 93. Fungal Foot Drugs Raw Materials
Table 94. Fungal Foot Drugs Raw Materials Suppliers in Global Market
Table 95. Typical Fungal Foot Drugs Downstream
Table 96. Fungal Foot Drugs Downstream Clients in Global Market
Table 97. Fungal Foot Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Fungal Foot Drugs Segment by Type in 2022
Figure 2. Fungal Foot Drugs Segment by Application in 2022
Figure 3. Global Fungal Foot Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Fungal Foot Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Fungal Foot Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Fungal Foot Drugs Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Fungal Foot Drugs Revenue in 2022
Figure 9. By Type - Global Fungal Foot Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Fungal Foot Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Fungal Foot Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Fungal Foot Drugs Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Fungal Foot Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Fungal Foot Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Fungal Foot Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Fungal Foot Drugs Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Fungal Foot Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Fungal Foot Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Fungal Foot Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Fungal Foot Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Fungal Foot Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Fungal Foot Drugs Sales Market Share, 2018-2029
Figure 23. US Fungal Foot Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Fungal Foot Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Fungal Foot Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Fungal Foot Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Fungal Foot Drugs Sales Market Share, 2018-2029
Figure 28. Germany Fungal Foot Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Fungal Foot Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Fungal Foot Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Fungal Foot Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Fungal Foot Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Fungal Foot Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Fungal Foot Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Fungal Foot Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Fungal Foot Drugs Sales Market Share, 2018-2029
Figure 37. China Fungal Foot Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Fungal Foot Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Fungal Foot Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Fungal Foot Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Fungal Foot Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Fungal Foot Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Fungal Foot Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Fungal Foot Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Fungal Foot Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Fungal Foot Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Fungal Foot Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Fungal Foot Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Fungal Foot Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Fungal Foot Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Fungal Foot Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Fungal Foot Drugs Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production Fungal Foot Drugs by Region, 2022 VS 2029
Figure 54. Fungal Foot Drugs Industry Value Chain
Figure 55. Marketing Channels

※参考情報

足菌腫治療薬は、足や爪に生じる真菌感染症の治療に用いられる医薬品です。足菌腫とは、特に足の指間や爪に見られる真菌の感染によって引き起こされる疾患で、通常「水虫」とも呼ばれる白癬（はくせん）や爪白癬（つめはくせん）が含まれます。これらの感染は、皮膚や爪にかゆみや炎症、変色、変形を引き起こすことがあります。足細菌腫治療薬は、その感染を治療するために設計されており、外用薬と内服薬の2つに大別されます。

足菌腫治療薬の特徴として、まず第一に効果的な抗真菌作用が挙げられます。これらの薬剤は、真菌の細胞壁や細胞膜に作用し、真菌の成長を抑制または殺菌する働きがあります。これにより、感染の進行を防ぎ、症状を緩和することが可能です。また、使用方法としては、外用薬であれば患部に直接塗布する形式が多く、内服薬であれば全身的に効果を及ぼすことができます。治療期間は感染の種類や重症度によって異なりますが、一般的に数週間から数ヶ月にわたることがあります。

一般的な足菌腫治療薬には、ケトコナゾール、フルコナゾール、イミダゾール系、トリコスポロン系などがあります。これらの薬剤はそれぞれ異なる作用機序を持ち、真菌の種類や感染の程度に応じて選択されます。例えば、イミダゾール系は、主要な皮膚真菌に効果的であり、外用薬として広く用いられています。フルコナゾールは、内服薬として使用されることが多く、特に爪白癬の治療に有効です。

足菌腫治療薬の用途としては、主に以下の点が挙げられます。まず、日常生活に支障をきたす症状を和らげることが重要です。真菌感染はかゆみや痛みを伴うことが多く、これが日常生活や仕事に対する影響を与えます。治療薬を使用することで、こうした不快な症状を軽減し、生活の質を向上させることが期待されます。さらに、足菌腫は感染症であるため、周囲への感染拡大を防ぐことも治療の大きな目的です。

足菌腫治療薬には、関連技術も豊富に存在します。足の衛生状態を保つことは、真菌感染の予防において極めて重要です。例えば、抗真菌成分を用いた特別な靴下や靴、入浴剤などが開発されており、これにより足の健康を維持しやすくなっています。さらに、最近では、デジタル技術を活用した診断オプションも増えてきており、スマートフォンアプリを使用して症状をモニタリングし、適切な治療法を選択する手助けが行われています。

しかし、足菌腫の治療には挑戦も存在します。真菌は耐性を持つ場合があり、特定の薬剤に対して効果が薄れることがあります。また、感染症は再発しやすいため、再発防止策も重要です。生活習慣の見直しや、足のケア、環境の改善に努めることで、真菌の繁殖を防ぐことが求められます。

最後に、足菌腫治療薬を使用する際には、正確に使用方法を守り、指示された通りに用いることが重要です。不適切な使用は、効果を減少させるばかりか、副作用を引き起こす可能性もあります。医師や専門家との相談を通じて、最適な治療を行うことが推奨されます。 רפואות 和名 medic薬は、感染症の進行を防ぎ、快適な生活を取り戻すために欠かせない存在です。


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 足菌腫治療薬の世界市場見通し2023年-2029年(Fungal Foot Drugs Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 皮膚科用OTC医薬品の世界市場見通し2023年-2029年
  • フットケア医薬品の世界市場見通し2023年-2029年
  • MSD医薬品の世界市場見通し2023年-2029年
  • 前頭洞炎治療薬の世界市場見通し2023年-2029年
  • 血液内科用医薬品の世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆